PARP1 inhibitor olaparib (Lynparza) exerts synthetic lethal effect against ligase 4-deficient melanomas-Reference-Cited by-同舟云学术

PARP1 inhibitor olaparib (Lynparza) exerts synthetic lethal effect against ligase 4-deficient melanomas

Published:2016-09-27 Issue:46 Volume:7 Page:75551-75560
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Czyż Małgorzata¹,Toma Monika²,Gajos-Michniewicz Anna¹,Majchrzak Kinga¹,Hoser Grazyna³,Szemraj Janusz⁴,Nieborowska-Skorska Margaret⁵,Cheng Phil⁶,Gritsyuk Daniel⁵,Levesque Mitchell⁶,Dummer Reinhard⁶,Sliwinski Tomasz²,Skorski Tomasz⁵

Affiliation:

1. Department of Molecular Biology of Cancer, Medical University of Lodz, 92-215 Lodz, Poland

2. Department of Molecular Genetics, University of Lodz, 90-236 Lodz, Poland

3. Department of Flow Cytometry, Medical Center for Postgraduate Education, 01-813 Warsaw, Poland

4. Department of Medical Biochemistry, Medical University of Lodz, 92-215 Lodz, Poland

5. Department of Microbiology and Immunology, Temple University Lewis Katz School of Medicine, Philadelphia, PA 19140, USA

6. Department of Dermatology, Faculty of Medicine, University Hospital Zürich, and University of Zürich, CH-8952, Zürich, Switzerland

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Star wars against leukemia: attacking the clones;Leukemia;2024-09-02

2. Polθ Inhibitor (ART558) Demonstrates a Synthetic Lethal Effect with PARP and RAD52 Inhibitors in Glioblastoma Cells;International Journal of Molecular Sciences;2024-08-23

3. Mammalian DNA ligases; roles in maintaining genome integrity;Journal of Molecular Biology;2024-01

4. Class I HDAC Inhibition Leads to a Downregulation of FANCD2 and RAD51, and the Eradication of Glioblastoma Cells;Journal of Personalized Medicine;2023-08-27

5. Patient-derived bladder cancer organoid model to predict sensitivity and feasibility of tailored precision therapy;Current Urology;2023-07-21